Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2021

01-02-2021 | Breast Cancer | Letter to the Editor

Letter to the editor re: Shah et al.: “The impact of monitoring techniques on progression to chronic breast cancer‑related lymphedema: a meta‑analysis comparing bioimpedance spectroscopy versus circumferential measurements”

Authors: Bolette Skjødt Rafn, Jan Christensen, Kira Bloomquist

Published in: Breast Cancer Research and Treatment | Issue 1/2021

Login to get access

Excerpt

Breast cancer-related lymphedema (BCRL) affects one in six cancer survivors with significant personal and societal impact to those affected, which in turn has brought research attention to evaluating strategies to prevent and/or detect and treat BCRL early. As such, the recently published meta-analysis by Shah and colleagues [1], which was conducted to evaluate the impact of BCRL monitoring techniques on the development of chronic BCRL, was read with keen interest. The authors concluded that monitoring with bioimpedance (BIS) reduce the cumulative incidence of chronic lymphedema by 69% and 81% compared to background literature and circumference monitoring, respectively. While this represents a compelling statement, we present below several factors that need to be considered before findings from this meta-analysis (MA) are used to guide changes to breast cancer care. …
Literature
3.
go back to reference Ridner SH, Dietrich MS, Cowher MS et al (2019) A randomized trial evaluating bioimpedance spectroscopy versus tape measurement for the prevention of lymphedema following treatment for breast cancer: interim analysis. Ann Surg Oncol 26(10):3250–3259. https://doi.org/10.1245/s10434-019-07344-5. With “Letter to Editor re: Ridner et al.: ‘A randomized trial evaluating bioimpedance spectroscopy versus tape measurement for the prevention of lymphedema following treatment for breast cancer: interim analysis’.by Barrio AV, Brunelle C, Morrow M, Taghian AG. Ann Surg Oncol 2019;26(Suppl3):863–864. https://doi.org/10.1245/s10434-019-07763-4” Ridner SH, Dietrich MS, Cowher MS et al (2019) A randomized trial evaluating bioimpedance spectroscopy versus tape measurement for the prevention of lymphedema following treatment for breast cancer: interim analysis. Ann Surg Oncol 26(10):3250–3259. https://​doi.​org/​10.​1245/​s10434-019-07344-5. With “Letter to Editor re: Ridner et al.: ‘A randomized trial evaluating bioimpedance spectroscopy versus tape measurement for the prevention of lymphedema following treatment for breast cancer: interim analysis’.by Barrio AV, Brunelle C, Morrow M, Taghian AG. Ann Surg Oncol 2019;26(Suppl3):863–864. https://​doi.​org/​10.​1245/​s10434-019-07763-4
Metadata
Title
Letter to the editor re: Shah et al.: “The impact of monitoring techniques on progression to chronic breast cancer‑related lymphedema: a meta‑analysis comparing bioimpedance spectroscopy versus circumferential measurements”
Authors
Bolette Skjødt Rafn
Jan Christensen
Kira Bloomquist
Publication date
01-02-2021
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2021
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-020-06081-8

Other articles of this Issue 1/2021

Breast Cancer Research and Treatment 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine